Literature DB >> 18675972

GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori.

Raoul Orvieto1, Roy Homburg, Simion Meltcer, Jacob Rabinson, Eyal Y Anteby, Shimon Scharf.   

Abstract

In an attempt to examine the influence of the type of GnRH analogue used during controlled ovarian hyperstimulation on IVF outcome in patients with an unfavorable outcome a priori, we studied 728 consecutive cycles in patients with repeated IVF failure. In patients with repeated failure, the GnRH agonist group showed significantly higher clinical pregnancy rate compared with the GnRH antagonist group (20.8% vs 14.5%).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18675972     DOI： 10.1016/j.fertnstert.2008.04.028

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  2 in total

1.  Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles.

Authors:  Qiaohong Lai; Hanwang Zhang; Guijing Zhu; Yufeng Li; Lei Jin; Long He; Zhijun Zhang; Ping Yang; Qilin Yu; Shu Zhang; Jun-Fa Xu; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

2.  Clinical outcome of preimplantation genetic diagnosis and screening using next generation sequencing.

Authors:  Yueqiu Tan; Xuyang Yin; Shuoping Zhang; Hui Jiang; Ke Tan; Jian Li; Bo Xiong; Fei Gong; Chunlei Zhang; Xiaoyu Pan; Fang Chen; Shengpei Chen; Chun Gong; Changfu Lu; Keli Luo; Yifan Gu; Xiuqing Zhang; Wei Wang; Xun Xu; Gábor Vajta; Lars Bolund; Huanming Yang; Guangxiu Lu; Yutao Du; Ge Lin
Journal:  Gigascience       Date:  2014-12-04       Impact factor: 6.524
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.